Heartburn drug Zantac recalled as FDA investigates probable carcinogen

The FDA has not recommend people stop taking the drug. However, the agency said people who want to discontinue prescriptions should talk to their doctor or pharmacist.

SHARE Heartburn drug Zantac recalled as FDA investigates probable carcinogen
The FDA last month said it discovered a probable carcinogen called NDMA, or nitrosodimethylamine, in the drug Zantac and its generic versions.

The FDA last month said it discovered a probable carcinogen called NDMA, or nitrosodimethylamine, in the drug Zantac and its generic versions.

AP Photos

Sanofi said Friday it will recall the widely-used heartburn drug Zantac from stores in the United States and Canada as the drugmaker and Food and Drug Administration investigate a probable carcinogen detected in the drug.

The FDA last month said it discovered a probable carcinogen called NDMA, or nitrosodimethylamine, in the drug Zantac and its generic versions. The FDA, Canadian and European drug regulators are evaluating possible risk to millions of people who take ranitidine, the active ingredient in Zantac and its generic versions.

”Due to inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products, Sanofi has made the decision to conduct the voluntary recall in the U.S. and Canada as the investigation continues,” the company said in a statement.

The FDA said preliminary tests detected levels of NDMA that equal or slightly exceed the amounts found in foods such as cured and grilled meats. 

The FDA has not recommend people stop taking the drug. However, the agency said people who want to discontinue prescriptions should talk to their doctor or pharmacist. Consumers who buy non-prescription versions can switch to other over-the-counter drugs; there are multiple drugs available for the same or similar uses, the FDA said. 

The FDA began evaluating ranitidine after New Haven, Connecticut-based Valisure, an online pharmacy, notified the agency that its testing found Zantac and generic versions contained NDMA levels significantly higher than the FDA’s recommended daily limits. That prompted the FDA to conduct its own tests of the drugs. It did not find the same levels of the probable carcinogen that Valisure did, but the levels were high enough to warrant followup testing.

The Latest
NBA
The Heat, champions of the Eastern Conference even after getting in as only the No. 8 seed, will take on the Western Conference champion Nuggets in Game 1 of the NBA Finals. The series starts in Denver on Thursday night.
The boy was standing on a sidewalk when someone in a white SUV drove up and an occupant began shooting. He was in good condition at a hospital.
At least one person was injured and many residents and business owners have been displaced. Demolition is expected to begin Tuesday morning, the city says.
The White Sox All-Star reliever allowed two runs and three hits in the Angels’ 6-4 win.